Your browser doesn't support javascript.
loading
Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain.
Hidalgo, M; Álvarez, R; Gallego, J; Guillén-Ponce, C; Laquente, B; Macarulla, T; Muñoz, A; Salgado, M; Vera, R; Adeva, J; Alés, I; Arévalo, S; Blázquez, J; Calsina, A; Carmona, A; de Madaria, E; Díaz, R; Díez, L; Fernández, T; de Paredes, B G; Gallardo, M E; González, I; Hernando, O; Jiménez, P; López, A; López, C; López-Ríos, F; Martín, E; Martínez, J; Martínez, A; Montans, J; Pazo, R; Plaza, J C; Peiró, I; Reina, J J; Sanjuanbenito, A; Yaya, R; Carrato, Alfredo.
Afiliação
  • Hidalgo M; Spanish National Cancer Centre, C/Melchor Fernández Almagro, 3, 28029, Madrid, Spain. mhidalgo@cnio.es.
  • Álvarez R; Beth Israel Deaconess Medical Center, Boston, USA. mhidalgo@cnio.es.
  • Gallego J; Department of Medical Oncology, Centro Integral Oncológico Clara Campal, Madrid, Spain.
  • Guillén-Ponce C; University Hospital of Elche, Elche, Spain.
  • Laquente B; Hospital Universitario Ramón y Cajal, Ctra. de Colmenar Viejo km. 9,100, 28034, Madrid, Spain.
  • Macarulla T; Institut Català d´Oncologia, Duran y Reynals Hospital, Hospitalet Llobregat, Barcelona, Spain.
  • Muñoz A; Vall d'Hebrón University Hospital, Barcelona, Spain.
  • Salgado M; University Hospital Gregorio Marañón, Madrid, Spain.
  • Vera R; University Hospital of Ourense, Ourense, Spain.
  • Adeva J; Complejo Hospitalario de Navarra, Pamplona, Spain.
  • Alés I; University Hospital 12 de Octubre, Madrid, Spain.
  • Arévalo S; Hospital Carlos Haya, Málaga, Spain.
  • Blázquez J; University Hospital Donostia, San Sebastián, Spain.
  • Calsina A; Department of Radiology, University Hospital Ramón y Cajal, Madrid, Spain.
  • Carmona A; MD Anderson Hospital, Madrid, Spain.
  • de Madaria E; Department of Palliative Care, Hospital Germans Trias I Pujol, Institut Catalá d´Oncologia, Badalona, Spain.
  • Díaz R; Department of Medical Oncology and Hematology, University Hospital Morales Messeguer, Murcia, Spain.
  • Díez L; Department of Gastroenterology, Hospital General Universitario de Alicante, Alicante, Spain.
  • Fernández T; Department of Medical Oncology, Hospital Universitari I Politècnic La Fe, Valencia, Spain.
  • de Paredes BG; Department of Surgery, Hospital Clínico San Carlos, Madrid, Spain.
  • Gallardo ME; Department of Medical Oncology, Hospital Son Llàtzer, Palma de Mallorca, Spain.
  • González I; Hospital Clínico San Carlos, Madrid, Spain.
  • Hernando O; Complejo Hospitalario Universitario de Pontevedra, Pontevedra, Spain.
  • Jiménez P; Complejo Hospitalario de Granada, Granada, Spain.
  • López A; Department of Radiotherapy, University Hospital HM Sanchinarro, Madrid, Spain.
  • López C; University Hospital HM Puerta del Sur, Madrid, Spain.
  • López-Ríos F; Department of Medical Oncology, Hospital Universitario Central de Asturias, Asturias, Spain.
  • Martín E; Hospital Universitario de Burgos, Burgos, Spain.
  • Martínez J; Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  • Martínez A; Department of Pathology, University Hospital HM Sanchinarro, Madrid, Spain.
  • Montans J; Department of Surgery, Hospital Universitario de la Princesa, Madrid, Spain.
  • Pazo R; Department of Medical Oncology, University Hospital Virgen de las Nieves, Granada, Spain.
  • Plaza JC; Hospital del Mar, Barcelona, Spain.
  • Peiró I; Department of Pathology, Centro Anatomopatológico, Madrid, Spain.
  • Reina JJ; Department of Medical Oncology, University Hospital Miguel Servet, Saragossa, Spain.
  • Sanjuanbenito A; Department of Pathology, University Hospital HM Sanchinarro, Madrid, Spain.
  • Yaya R; Department of Endocrinology, Instituto Catalán de Oncología, Hospital Duran I Reynals, Hospitalet de Llobregat, Barcelona, Spain.
  • Carrato A; Department of Medical Oncology, University Hospital Virgen de la Macarena, Seville, Spain.
Clin Transl Oncol ; 19(6): 667-681, 2017 Jun.
Article em En | MEDLINE | ID: mdl-27995549
ABSTRACT
The management of patients with pancreatic cancer has advanced over the last few years. We convey a multidisciplinary group of experts in an attempt to stablish practical guidelines for the diagnoses, staging and management of these patients. This paper summarizes the main conclusions of the working group. Patients with suspected pancreatic ductal adenocarcinoma should be rapidly evaluated and referred to high-volume centers. Multidisciplinary supervision is critical for proper diagnoses, staging and to frame a treatment plan. Surgical resection together with chemotherapy offers the highest chance for cure in early stage disease. Patients with advanced disease should be classified in treatment groups to guide systemic treatment. New chemotherapeutic regimens have resulted in improved survival. Symptomatic management is critical in this disease. Enrollment in a clinical trial is, in general, recommended.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Clin Transl Oncol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Clin Transl Oncol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Espanha